-+ 0.00%
-+ 0.00%
-+ 0.00%

According to the 2025 “National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalogue” published by the National Health Insurance Administration, two domestically produced anti-influenza virus drugs that were newly approved for marketing this year successfully entered the catalogue, namely Onradivir tablets from Zhongsheng Pharmaceutical and masulasavir tablets from Qingfeng Pharmaceutical.

Zhitongcaijing·12/07/2025 03:09:00
Listen to the news
According to the 2025 “National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalogue” published by the National Health Insurance Administration, two domestically produced anti-influenza virus drugs that were newly approved for marketing this year successfully entered the catalogue, namely Onradivir tablets from Zhongsheng Pharmaceutical and masulasavir tablets from Qingfeng Pharmaceutical.